Biofrontera Inc. (NASDAQ: BFRI) Stock Competitors & Peer Comparison
See BFRI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BFRI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BFRI | $1.48 | +3.87% | 18.9M | -2.69 | -$0.55 | N/A |
| RPRX | $61.45 | -0.45% | 26.9B | 11.54 | $5.25 | +1.52% |
| CORT | $121.29 | +1.90% | 13.1B | 345.86 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $68.53 | -9.03% | 6.3B | 507.50 | $0.14 | N/A |
| KNSA | $79.37 | -1.77% | 6B | 87.19 | $0.90 | N/A |
| TRLV | $10.91 | +8.13% | 1.7B | -24.40 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $21.74 | +3.82% | 1.3B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
BFRI vs RPRX Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, RPRX has a market cap of 26.9B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while RPRX trades at $61.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas RPRX's P/E ratio is 11.54. In terms of profitability, BFRI's ROE is -1.28%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, BFRI is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
BFRI vs CORT Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, CORT has a market cap of 13.1B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while CORT trades at $121.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas CORT's P/E ratio is 345.86. In terms of profitability, BFRI's ROE is -1.28%, compared to CORT's ROE of +0.08%. Regarding short-term risk, BFRI is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
BFRI vs WBA Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas WBA's P/E ratio is -1.64. In terms of profitability, BFRI's ROE is -1.28%, compared to WBA's ROE of -0.42%. Regarding short-term risk, BFRI is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
BFRI vs LQDA Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, LQDA has a market cap of 6.3B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while LQDA trades at $68.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas LQDA's P/E ratio is 507.50. In terms of profitability, BFRI's ROE is -1.28%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, BFRI is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
BFRI vs KNSA Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while KNSA trades at $79.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas KNSA's P/E ratio is 87.19. In terms of profitability, BFRI's ROE is -1.28%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, BFRI is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
BFRI vs TRLV Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, TRLV has a market cap of 1.7B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while TRLV trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas TRLV's P/E ratio is -24.40. In terms of profitability, BFRI's ROE is -1.28%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, BFRI is less volatile compared to TRLV. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
BFRI vs HROWL Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas HROWL's P/E ratio is N/A. In terms of profitability, BFRI's ROE is -1.28%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, BFRI is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
BFRI vs HROWM Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas HROWM's P/E ratio is N/A. In terms of profitability, BFRI's ROE is -1.28%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, BFRI is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
BFRI vs LTGO Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, LTGO has a market cap of 1.3B. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while LTGO trades at $21.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas LTGO's P/E ratio is N/A. In terms of profitability, BFRI's ROE is -1.28%, compared to LTGO's ROE of N/A. Regarding short-term risk, BFRI is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check LTGO's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
BFRI vs CUVL Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, CUVL has a market cap of 393.3M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while CUVL trades at $7.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas CUVL's P/E ratio is N/A. In terms of profitability, BFRI's ROE is -1.28%, compared to CUVL's ROE of N/A. Regarding short-term risk, BFRI is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
BFRI vs LFMDP Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, LFMDP has a market cap of 158.9M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while LFMDP trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas LFMDP's P/E ratio is -718.03. In terms of profitability, BFRI's ROE is -1.28%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, BFRI is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check LFMDP's competition here
LifeMD, Inc. (NASDAQ: LFMD)
BFRI vs LFMD Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, LFMD has a market cap of 158.6M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while LFMD trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas LFMD's P/E ratio is -6.56. In terms of profitability, BFRI's ROE is -1.28%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, BFRI is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check LFMD's competition here
Stablecoin Development Corp. (AMEX: SDEV)
BFRI vs SDEV Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, SDEV has a market cap of 55.5M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while SDEV trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas SDEV's P/E ratio is -0.19. In terms of profitability, BFRI's ROE is -1.28%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, BFRI is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check SDEV's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
BFRI vs CIRC Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, CIRC has a market cap of 54M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while CIRC trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas CIRC's P/E ratio is -1.36. In terms of profitability, BFRI's ROE is -1.28%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, BFRI is less volatile compared to CIRC. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check CIRC's competition here
Rite Aid Corporation (NYSE: RAD)
BFRI vs RAD Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas RAD's P/E ratio is -0.05. In terms of profitability, BFRI's ROE is -1.28%, compared to RAD's ROE of +2.76%. Regarding short-term risk, BFRI is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
BFRI vs GLTO Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas GLTO's P/E ratio is -1.78. In terms of profitability, BFRI's ROE is -1.28%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, BFRI is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check GLTO's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
BFRI vs NSRX Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, NSRX has a market cap of 33.2M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while NSRX trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas NSRX's P/E ratio is -5.35. In terms of profitability, BFRI's ROE is -1.28%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, BFRI is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
BFRI vs SCYX Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, SCYX has a market cap of 32.8M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while SCYX trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas SCYX's P/E ratio is -1.53. In terms of profitability, BFRI's ROE is -1.28%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, BFRI is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check SCYX's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
BFRI vs AIXC Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, AIXC has a market cap of 23.8M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while AIXC trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas AIXC's P/E ratio is -0.13. In terms of profitability, BFRI's ROE is -1.28%, compared to AIXC's ROE of -0.97%. Regarding short-term risk, BFRI is less volatile compared to AIXC. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check AIXC's competition here
Cerenome, Inc. (NASDAQ: CNSY)
BFRI vs CNSY Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, CNSY has a market cap of 20.6M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while CNSY trades at $3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas CNSY's P/E ratio is -0.42. In terms of profitability, BFRI's ROE is -1.28%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, BFRI is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check CNSY's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
BFRI vs CJJD Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas CJJD's P/E ratio is -0.46. In terms of profitability, BFRI's ROE is -1.28%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, BFRI is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
BFRI vs SSY Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas SSY's P/E ratio is -2.86. In terms of profitability, BFRI's ROE is -1.28%, compared to SSY's ROE of -0.09%. Regarding short-term risk, BFRI is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
BFRI vs POM Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, POM has a market cap of 7.1M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while POM trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas POM's P/E ratio is -0.21. In terms of profitability, BFRI's ROE is -1.28%, compared to POM's ROE of +0.16%. Regarding short-term risk, BFRI is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check POM's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
BFRI vs BGMS Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, BGMS has a market cap of 4.8M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while BGMS trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas BGMS's P/E ratio is -0.25. In terms of profitability, BFRI's ROE is -1.28%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, BFRI is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check BGMS's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
BFRI vs PAVS Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, PAVS has a market cap of 4.5M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while PAVS trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas PAVS's P/E ratio is -0.06. In terms of profitability, BFRI's ROE is -1.28%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, BFRI is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
BFRI vs HKPD Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, HKPD has a market cap of 4.4M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while HKPD trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas HKPD's P/E ratio is -6.67. In terms of profitability, BFRI's ROE is -1.28%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, BFRI is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check HKPD's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
BFRI vs MDVL Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas MDVL's P/E ratio is -0.05. In terms of profitability, BFRI's ROE is -1.28%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, BFRI is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
BFRI vs ATNFW Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas ATNFW's P/E ratio is N/A. In terms of profitability, BFRI's ROE is -1.28%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, BFRI is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
BFRI vs BGMSP Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, BFRI's ROE is -1.28%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, BFRI is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
BFRI vs AZNH Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas AZNH's P/E ratio is 38.35. In terms of profitability, BFRI's ROE is -1.28%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, BFRI is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
BFRI vs LFLYW Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, BFRI's ROE is -1.28%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, BFRI is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
BFRI vs SBFMW Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, SBFMW has a market cap of 249.8K. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while SBFMW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas SBFMW's P/E ratio is N/A. In terms of profitability, BFRI's ROE is -1.28%, compared to SBFMW's ROE of -0.24%. Regarding short-term risk, BFRI is less volatile compared to SBFMW. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check SBFMW's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
BFRI vs IPXL Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas IPXL's P/E ratio is -10.11. In terms of profitability, BFRI's ROE is -1.28%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, BFRI is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check IPXL's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
BFRI vs OREX Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, OREX has a market cap of 0. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas OREX's P/E ratio is -0.14. In terms of profitability, BFRI's ROE is -1.28%, compared to OREX's ROE of -0.54%. Regarding short-term risk, BFRI is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check OREX's competition here
Shire plc (NASDAQ: SHPG)
BFRI vs SHPG Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas SHPG's P/E ratio is 11.35. In terms of profitability, BFRI's ROE is -1.28%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, BFRI is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check SHPG's competition here
POZEN Inc. (NASDAQ: POZN)
BFRI vs POZN Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, POZN has a market cap of 0. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas POZN's P/E ratio is N/A. In terms of profitability, BFRI's ROE is -1.28%, compared to POZN's ROE of +0.61%. Regarding short-term risk, BFRI is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for BFRI.Check POZN's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
BFRI vs CPD Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, CPD has a market cap of 0. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas CPD's P/E ratio is N/A. In terms of profitability, BFRI's ROE is -1.28%, compared to CPD's ROE of N/A. Regarding short-term risk, BFRI is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check CPD's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
BFRI vs ESRX Comparison August 2026
Biofrontera Inc. (NASDAQ: BFRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFRI stands at 18.9M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, BFRI is priced at $1.48 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFRI currently has a P/E ratio of -2.69, whereas ESRX's P/E ratio is 10.69. In terms of profitability, BFRI's ROE is -1.28%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, BFRI is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for BFRI.Check ESRX's competition here